Cancer Research UK logo.
SearchDonate
  • Search

A study of T3P-Y058-739 for cancer (T3P)

Overview

Cancer types:

All cancer types

Status:

Open

Phase:

Phase 1/2

Details

This study is looking at a drug called T3P-Y058-739 (T3P) for solid cancers.

A solid cancer is any cancer apart from a blood cancer such as leukaemia, lymphoma and myeloma.

Recruitment start: 2 June 2022

Recruitment end: 28 February 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Kevin Harrington

Supported by

T3 Pharmaceuticals AG

IQVA BIOTECH

Last reviewed: 14 October 2024

CRUK internal database number: 18049

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.